Hubei Guangji Pharmaceutical Co Ltd Cash Flow Quality Index
Hubei Guangji Pharmaceutical Co Ltd cash flow quality index. Hubei Guangji Pharmaceutical Co Ltd (000952) has a Cash Flow Quality Index of -4.76x as of June 2023. Operating cash flow of CN¥-86.71 Million is below net income of CN¥18.23 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how well can Hubei Guangji Pharmaceutical Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Hubei Guangji Pharmaceutical Co Ltd (1998–2022)
Cash flow quality index of Hubei Guangji Pharmaceutical Co Ltd from 1998 to 2022. Historical Cash Flow Quality Index for Hubei Guangji Pharmaceutical Co Ltd across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. See net asset quality index of Hubei Guangji Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
Hubei Guangji Pharmaceutical Co Ltd Cash Flow Quality Index by Year (1998–2022)
Hubei Guangji Pharmaceutical Co Ltd cash flow quality index by year from 1998 to 2022. Year-by-year earnings quality comparison for Hubei Guangji Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 000952 cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.94x | CN¥45.08 Million | CN¥47.72 Million | ▲ +31.7% |
| 2021 | 0.72x | CN¥75.91 Million | CN¥105.81 Million | ▼ -57.8% |
| 2020 | 1.70x | CN¥119.38 Million | CN¥70.30 Million | ▼ -2.0% |
| 2019 | 1.73x | CN¥144.20 Million | CN¥83.18 Million | ▲ +29.9% |
| 2018 | 1.33x | CN¥231.44 Million | CN¥173.41 Million | ▼ -20.8% |
| 2017 | 1.69x | CN¥178.83 Million | CN¥106.06 Million | ▲ +46.7% |
| 2016 | 1.15x | CN¥167.07 Million | CN¥145.32 Million | ▲ +163.5% |
| 2015 | -1.81x | CN¥-33.35 Million | CN¥18.42 Million | ▼ -101.8% |
| 2011 | 102.56x | CN¥81.88 Million | CN¥798.36K | ▲ +1155.0% |
| 2010 | 8.17x | CN¥77.18 Million | CN¥9.44 Million | ▲ +1348.5% |
| 2009 | -0.65x | CN¥-24.35 Million | CN¥37.20 Million | ▼ -128.9% |
| 2008 | 2.27x | CN¥220.70 Million | CN¥97.35 Million | ▲ +33.6% |
| 2007 | 1.70x | CN¥331.98 Million | CN¥195.56 Million | ▼ -78.9% |
| 2006 | 8.04x | CN¥125.95 Million | CN¥15.66 Million | ▲ +27.3% |
| 2005 | 6.32x | CN¥54.14 Million | CN¥8.57 Million | ▲ +1651.2% |
| 2004 | -0.41x | CN¥-3.32 Million | CN¥8.14 Million | ▲ +79.6% |
| 2003 | -2.00x | CN¥-15.40 Million | CN¥7.70 Million | ▼ -152.1% |
| 2002 | 3.84x | CN¥76.20 Million | CN¥19.87 Million | ▲ +521.0% |
| 2001 | -0.91x | CN¥-22.40 Million | CN¥24.59 Million | ▼ -157.4% |
| 2000 | 1.59x | CN¥48.57 Million | CN¥30.62 Million | ▼ -27.3% |
| 1999 | 2.18x | CN¥68.57 Million | CN¥31.42 Million | ▲ +467.5% |
| 1998 | -0.59x | CN¥-15.29 Million | CN¥25.75 Million | — |